SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-082429
Filing Date
2020-07-09
Accepted
2020-07-09 17:20:58
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2024336-1_s3.htm S-3 646781
2 EXHIBIT 1.1 tm2024336d2_ex1-1.htm EX-1.1 208623
3 EXHIBIT 4.2 tm2024336d2_ex4-2.htm EX-4.2 388797
4 EXHIBIT 4.4 tm2024336d2_ex4-4.htm EX-4.4 395411
5 EXHIBIT 5.1 tm2024336d2_ex5-1.htm EX-5.1 24667
6 EXHIBIT 5.2 tm2024336d2_ex5-2.htm EX-5.2 10243
7 EXHIBIT 23.3 tm2024336d2_ex23-3.htm EX-23.3 4530
8 GRAPHIC tm2024336d2_ex5-2img01.jpg GRAPHIC 10267
9 GRAPHIC lg_marinusphar-4clr.jpg GRAPHIC 12597
  Complete submission text file 0001104659-20-082429.txt   1711891
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-239780 | Film No.: 201021170
SIC: 2834 Pharmaceutical Preparations